Jill Wu
Stock Analyst at CMB International Securities
(4.83)
# 452
Out of 5,070 analysts
203
Total ratings
53.9%
Success rate
25.5%
Average return
Main Sectors:
Stocks Rated by Jill Wu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $130.25 → $138.63 | $89.30 | +55.24% | 15 | Oct 16, 2026 | |
| HKG: 2637 Fujian Haixi Pharmaceuticals Co., Ltd. | Reiterated: Buy | $280.00 | $150.30 | +86.29% | 2 | Sep 18, 2026 | |
| HKG: 6699 Angelalign Technology Inc. | Reiterated: Buy | $91.89 → $114.21 | $80.30 | +42.23% | 5 | Sep 2, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $383.47 → $284.50 | $171.60 | +65.79% | 4 | Sep 1, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $185.80 → $138.42 | $93.10 | +48.68% | 11 | Aug 31, 2026 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $47.19 → $49.12 | $33.96 | +44.64% | 9 | Aug 28, 2026 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $39.00 → $60.00 | $49.44 | +21.36% | 11 | Aug 27, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Reiterated: Buy | $82.00 → $93.00 | $76.40 | +21.73% | 4 | Aug 25, 2026 | |
| HKG: 1530 3SBio Inc. | Reiterated: Buy | $34.87 → $34.78 | $14.45 | +140.69% | 11 | Aug 24, 2026 | |
| HKG: 2696 Shanghai Henlius Biotech, Inc. | Reiterated: Buy | $99.78 → $101.66 | $53.90 | +88.61% | 8 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.05 → $13.44 | $8.78 | +53.16% | 16 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92.55 → $99.58 | $65.95 | +50.99% | 5 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38.70 → $38.42 | $22.24 | +72.75% | 11 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $507.11 → $642.29 | $472.80 | +35.85% | 10 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $392 → $442 | $384.50 | +15.04% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $36 | $30.11 | +18.73% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $660 | $687.37 | -3.98% | 8 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11.95 → $18.31 | $12.52 | +46.25% | 4 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.40 → $8.70 | $5.37 | +62.01% | 4 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.34 | $5.38 | +92.19% | 1 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80.27 | $40.72 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34.03 → $31.39 | $23.04 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.57 | $6.17 | n/a | 2 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35.04 → $33.68 | $30.70 | n/a | 3 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21.41 → $52.39 | $4.92 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19.59 → $21.09 | $67.05 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.43 → $3.33 | $2.23 | n/a | 3 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.36 → $8.57 | $26.76 | n/a | 6 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.20 → $5.27 | $4.47 | n/a | 4 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.65 | $0.89 | n/a | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16.01 → $13.78 | $0.58 | n/a | 2 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.36 | $45.26 | n/a | 1 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23.89 → $23.80 | $5.82 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $57.97 | $3.55 | n/a | 1 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.15 | $10.88 | n/a | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.43 | n/a | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33.21 | $0.71 | n/a | 1 | Jul 24, 2023 |
Innovent Biologics, Inc.
Oct 16, 2026
Reiterated: Buy
Price Target: $130.25 → $138.63
Current: $89.30
Upside: +55.24%
Fujian Haixi Pharmaceuticals Co., Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: $280.00
Current: $150.30
Upside: +86.29%
Angelalign Technology Inc.
Sep 2, 2026
Reiterated: Buy
Price Target: $91.89 → $114.21
Current: $80.30
Upside: +42.23%
Duality Biotherapeutics, Inc.
Sep 1, 2026
Reiterated: Buy
Price Target: $383.47 → $284.50
Current: $171.60
Upside: +65.79%
Akeso, Inc.
Aug 31, 2026
Reiterated: Buy
Price Target: $185.80 → $138.42
Current: $93.10
Upside: +48.68%
Hansoh Pharmaceutical Group Company Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $47.19 → $49.12
Current: $33.96
Upside: +44.64%
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $39.00 → $60.00
Current: $49.44
Upside: +21.36%
WuXi XDC Cayman Inc.
Aug 25, 2026
Reiterated: Buy
Price Target: $82.00 → $93.00
Current: $76.40
Upside: +21.73%
3SBio Inc.
Aug 24, 2026
Reiterated: Buy
Price Target: $34.87 → $34.78
Current: $14.45
Upside: +140.69%
Shanghai Henlius Biotech, Inc.
Aug 24, 2026
Reiterated: Buy
Price Target: $99.78 → $101.66
Current: $53.90
Upside: +88.61%
Aug 21, 2026
Reiterated: Buy
Price Target: $13.05 → $13.44
Current: $8.78
Upside: +53.16%
Aug 20, 2026
Reiterated: Buy
Price Target: $92.55 → $99.58
Current: $65.95
Upside: +50.99%
Aug 19, 2026
Reiterated: Buy
Price Target: $38.70 → $38.42
Current: $22.24
Upside: +72.75%
Aug 19, 2026
Reiterated: Buy
Price Target: $507.11 → $642.29
Current: $472.80
Upside: +35.85%
Aug 7, 2026
Reiterated: Buy
Price Target: $392 → $442
Current: $384.50
Upside: +15.04%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $30.11
Upside: +18.73%
Jul 27, 2026
Reiterated: Buy
Price Target: $620 → $660
Current: $687.37
Upside: -3.98%
Apr 24, 2026
Reiterated: Buy
Price Target: $11.95 → $18.31
Current: $12.52
Upside: +46.25%
Mar 30, 2026
Reiterated: Buy
Price Target: $9.40 → $8.70
Current: $5.37
Upside: +62.01%
Mar 12, 2026
Reiterated: Buy
Price Target: $10.34
Current: $5.38
Upside: +92.19%
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80.27
Current: $40.72
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: $34.03 → $31.39
Current: $23.04
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $7.57
Current: $6.17
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $35.04 → $33.68
Current: $30.70
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $21.41 → $52.39
Current: $4.92
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $19.59 → $21.09
Current: $67.05
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $4.43 → $3.33
Current: $2.23
Upside: n/a
Sep 2, 2024
Reiterated: Buy
Price Target: $10.36 → $8.57
Current: $26.76
Upside: n/a
Aug 30, 2024
Reiterated: Buy
Price Target: $7.20 → $5.27
Current: $4.47
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $1.65
Current: $0.89
Upside: n/a
Apr 9, 2024
Reiterated: Buy
Price Target: $16.01 → $13.78
Current: $0.58
Upside: n/a
Aug 29, 2023
Reiterated: Buy
Price Target: $22.36
Current: $45.26
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23.89 → $23.80
Current: $5.82
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: $57.97
Current: $3.55
Upside: n/a
Aug 23, 2023
Reiterated: Buy
Price Target: $8.15
Current: $10.88
Upside: n/a
Aug 3, 2023
Rated: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Jul 24, 2023
Initiated Coverage: Buy
Price Target: $33.21
Current: $0.71
Upside: n/a